Pharmaceutical Care Management Association (PCMA) President and CEO Mark Merritt released the following statement on reports of yet another round of massive price hikes by drug manufacturers.
WASHINGTON, July 5, 2018 /PRNewswire-USNewswire/ -- Pharmaceutical Care Management Association (PCMA) President and CEO Mark Merritt released the following statement on reports of yet another round of massive price hikes by drug manufacturers.
“News of recent price increases by drugmakers further confirms that the easiest way to lower costs would be for drug companies to lower their prices.
This news follows an Office of Inspector General, Health and Human Services report that debunked the myth that drugmakers have somehow been compelled to raise prices because of the discounts and rebates health plans and PBMs demand to reduce overall costs.”
PCMA is the national association representing America’s pharmacy benefit managers (PBMs). PBMs administer prescription drug plans for more than 266 million Americans who have health insurance from a variety of sponsors including: commercial health plans, self-insured employer plans, union plans, Medicare Part D plans, the Federal Employees Health Benefits Program (FEHBP), state government employee plans, Medicaid plans, and others.
View original content with multimedia:http://www.prnewswire.com/news-releases/drug-manufacturers-continue-to-significantly-increase-prescription-drug-prices-300676706.html
SOURCE Pharmaceutical Care Management Association
